Fig. 3From: Assessment of target-mediated uptake with immuno-PET: analysis of a phase I clinical trial with an anti-CD44 antibodyBlood pool concentrations of 89Zr-RG7356 and RG7356. a Radioactivity concentrations of 89Zr-RG7356 in blood pool as function of time. b Antibody concentrations of RG7356 in blood pool as function of time. c AUC of the time antibody concentration curve of RG7356 in blood pool as function of antibody dose. Data is presented as mean; error bars represent SDBack to article page